Inovio Pharmaceuticals Inc (INO) Is Not Likely To Be The Same Tomorrow

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Recently, Yahoo Finance discussed the stock, revealing that INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Stocks Info

Inovio Pharmaceuticals Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Inovio Pharmaceuticals Inc is $306.61M. A total of 0.97 million shares were traded on the day, compared to an average of 548.95K shares.

In the most recent transaction, Zoth Lota S. sold 5,700 shares of INO for 0.56 per share on Jun 05 ’23. After the transaction, the Director now owns 52,716 company shares.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, INO has a high of $14.69 and a low of $3.89.

As of this writing, INO has an earnings estimate of -$0.99 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of -$0.86 per share and a lower estimate of -$1.17. The company reported an EPS of -$1.56 in the last quarter, which was -2.60% lower than expectations of -$1.52.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. INO’s latest balance sheet shows that the firm has $401.31M in Cash & Short Term Investments as of fiscal 2021. There were $33.02M in debt and $65.74M in liabilities at the time. Its Book Value Per Share was $5.15, while its Total Shareholder’s Equity was $399.67M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for INO is Buy with a score of 3.80.

Most Popular

Related Posts